A Review of the Current FDA-Approved Antibody-Drug Conjugates: Landmark Clinical Trials and Indications-Reference-Cited by-同舟云学术

A Review of the Current FDA-Approved Antibody-Drug Conjugates: Landmark Clinical Trials and Indications

Published:2023-11-29 Issue:1 Volume:38 Page:39-54
ISSN:1178-2595
Container-title:Pharmaceutical Medicine
language:en
Short-container-title:Pharm Med

Author:

Kesireddy Meghana^ORCID,Kothapalli Srikanth Reddy,Gundepalli Sai Giridhar,Asif Samia

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40290-023-00505-8.pdf

Reference71 articles.

1. Key Cancer Data and Key Figures on IARC: 2020–2021. International agency for research on cancer. https://www.iarc.who.int/biennial-report-2020-2021web/. Accessed.

2. DeVita VT, Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68(21):8643–53. https://doi.org/10.1158/0008-5472.CAN-07-6611. (in eng).

3. Pahl A, Lutz C, Hechler T. Amanitins and their development as a payload for antibody-drug conjugates. Drug Discov Today Technol. 2018;30:85–9. https://doi.org/10.1016/j.ddtec.2018.08.005. (in eng).

4. Chari RV. Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc Chem Res. 2008;41(1):98–107. https://doi.org/10.1021/ar700108g. (in eng).

5. Strebhardt K, Ullrich A. Paul Ehrlich’s magic bullet concept: 100 years of progress. Nat Rev Cancer. 2008;8(6):473–80. https://doi.org/10.1038/nrc2394. (in eng).

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Varianten biotechnologischer Arzneistoffe in der Dermatologie;Die Dermatologie;2024-08-22

2. Design and synthesis of novel site-specific antibody-drug conjugates that target TROP2;Bioorganic & Medicinal Chemistry;2024-08

3. Future of Cancer Treatment Guidelines: Integrating Real-World Insights for Equitable Cancer Care;JCO Clinical Cancer Informatics;2024-06

4. Novel Drug Delivery Systems: An Important Direction for Drug Innovation Research and Development;Pharmaceutics;2024-05-16

5. Approaches to Improve the Translation of Safety, Pharmacokinetics and Therapeutic Index of ADCs;Xenobiotica;2024-05-11